IntrinsicIntrinsic
← Scroll for more →

Financial Statements — ADAG

Balance Sheet

(in millions USD)
MetricQ4 2025Q2 2025Q4 2024Q2 2024Q4 2023Q4 2022Q4 2021
Cash & Equivalents74.5262.8385.1995.67109.93143.76174.39
Short-term Investments0.000.000.000.00------
Accounts Receivable------------3.00
Total Current Assets77.3865.3687.7898.80113.44149.32185.95
Property, Plant & Equipment0.720.901.131.441.842.783.49
Total Non-current Assets*0.891.151.491.982.293.083.56
Total Assets78.2666.5289.27100.78115.73152.40189.51
Accounts Payable2.883.634.243.373.093.673.32
Short-term Debt4.986.6417.7915.978.4013.624.50
Total Current Liabilities25.1728.5238.1839.5231.4655.0829.82
Long-term Debt1.140.420.424.5613.5414.152.99
Total Non-current Liabilities*1.190.090.564.6713.7114.233.13
Total Liabilities26.3628.6038.7444.1945.1769.3132.95
Retained Earnings(328.78)(324.65)(311.18)(294.76)(277.75)(258.81)(178.83)
Total Stockholder Equity35.3537.9150.5256.5970.5683.09156.56
← Scroll for more columns →

* Derived from reported values

Income Statement

(in millions USD) (except per-share rows)
MetricQ2 2025Q2 2024
Total Revenue--17.30
Research & Development12.0214.72
Selling, General & Admin3.673.60
Operating Income(15.69)(18.32)
Interest Expense--0.43
Pretax Income(13.48)(17.01)
Tax Provision0.000.00
Net Income(13.48)(17.01)
Basic EPS(0.23)(0.31)
Diluted EPS(0.23)(0.31)
← Scroll for more columns →

Cash Flow Statement

(in millions USD)
MetricQ2 2025Q2 2024
Operating Cash Flow(11.13)(13.37)
Capital Expenditures0.000.01
Free Cash Flow*(11.13)(13.39)
Investing Cash Flow0.240.45
Financing Cash Flow(11.60)(1.44)
← Scroll for more columns →

* Derived from reported values